Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMART Trial: Imatinib and Artesunate in CML
NCT07022743Phase 2Active, not recruiting
- Sponsor
- Obafemi Awolowo University
- Start
- Jul 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artesunate in chronic myeloid leukemia (CML), sponsored by Obafemi Awolowo University. Started Jul 2025; status: active, not recruiting.
02
Drugs
artesunate
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT07022743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07022743.